Price
No data yet.
Social Signal Score
Analyst Ratings
1 analystRevenue
$2.84M-10.84%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Eric C. Hines
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 15
- Beta
- 1.07
- Country
- US
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- -18.60
Financials
Revenue
$2.84M-10.8%Net Income
$-1.06MEBITDA
$-1.04MFree Cash Flow
$-589.3KEPS (diluted)
$-0.01Shares Outstanding (diluted)
93.13M+219.4%Operating Expenses
$2.95MCash & Debt
$2.07MRevenue by Segment (annual)
$6.41MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $8.97M | $-5.72M | $-0.07 |
| 2024 | $8.63M | $-4.71M | $-0.06 |
| 2023 | $9.83M | $-6.93M | $-0.10 |
| 2022 | $8.81M | $-8.71M | $-0.12 |
| 2021 | $10.30M | $-6.82M | $-0.10 |
| 2020 | $5.44M | $-7.34M | $-0.12 |
| 2019 | $8.37M | $-7.52M | $-0.17 |
| 2018 | $9.62M | $-7.43M | $-0.21 |
| 2017 | $11.28M | $-5.19M | $-0.16 |
| 2016 | $10.48M | $-5.95M | $-0.22 |
| 2015 | $9.49M | $-5.47M | $-0.26 |
| 2014 | $10.33M | $-1.70M | $-0.08 |
| 2013 | $10.01M | $1.46M | $0.09 |
| 2012 | $8.65M | $-870.3K | $-0.05 |
Valuation
MLSShas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
50-64.29%Social Signal Score
Mentions (4)
- Newsglobenewswire.com·7d ago·Neutral
Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business CompuFlo Builds Momentum as Physician Adoption, Reimbursement Access, Commercial Coverage and Clinical Evidence Expand CompuFlo Builds Momentum as Physician Adoption, Reimbursement Access, Commercial Coverage and Clinical Evidence Expand
View source ↗ - Newsglobenewswire.com·20d ago·Negative
Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor ROSELAND, N.J., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery and injection technologies, today announced that Sudhir Rao, M.D.
View source ↗ - Newsseekingalpha.com·52d ago·Positive
Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript
View source ↗ - Newsglobenewswire.com·53d ago·Negative
…utlook for Double-Digit Revenue Growth, Including Significant Growth in CompuFlo® Sales ROSELAND, N.J., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the three and six months ended June 30, 2026.
View source ↗
Earnings
Thu, Nov 12(in 5 weeks)
Consensus estimate $-0.01 per share
Typical surprise -33.3% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 13$-0.01 vs $-0.01beat
- Wed, May 13$-0.01 vs $-0.01beat
- Tue, Mar 31$-0.02 vs $-0.01miss
- Thu, Nov 13$-0.01 vs $-0.01beat
- Thu, Aug 14$-0.02 vs $-0.01miss
- Thu, May 15$-0.02 vs $-0.01miss
Estimates and results for MLSS via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by MLSS officers and directors.
- Bought
- $171k
- Sold
- $881k
9 trades
55 trades
- Bp4 S.r.l.sold
- Bp4 S.r.l.sold
- Bp4 S.r.l.sold
- Bp4 S.r.l.sold
- Bp4 S.r.l.sold
- Bp4 S.r.l.sold
- Bp4 S.r.l.sold
- Bp4 S.r.l.sold
36 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in MLSS.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.